Wed. Jun 18th, 2025

Product Name :
Asfotase alfa Biosimilar

Host species :
Homo sapiens

Species reactivity :
Human

Form:
Liquid

Storage buffer :
0.01M PBS, pH 7.4.

Concentration:
0.5 mg/ml

Purity :
>95% by SDS-PAGE.

Clonality:

Applications :
Research Grade Biosimilar

Target :
Alkaline phosphatase liver/bone/kidney isozyme, AP-TNAP, TNSALP, Alkaline phosphatase, tissue-nonspecific isozyme, ALPL

Purification:
XtenCHO

Endotoxin level.:
Please contact with the lab for this information.

Expression system :
XtenCHO

Accession :
P05186

Stability and Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Alternative Names:
ENB-0040, STRENSIQ™

Note:
For research use only. Not suitable for clinical or therapeutic use.

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Tegaserod Formula Etokimab Description PMID:34758391 MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com